Akari Therapeutics, Stock Forecast

Stock Price Forecast

The 2 analysts that cover Akari Therapeutics, stock have a consensus rating of "Strong Buy" and an average price target of $3.30, which forecasts a 315.83% increase in the stock price over the next year. The lowest target is $1.60 and the highest is $5.00.

Price Target: $3.30 (+315.83%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.60	$3.30	$5.00	$5.00
Change	+101.61%	+315.83%	+530.04%	+530.04%

Analyst Ratings

The average analyst rating for Akari Therapeutics, stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	2	2	2	1	1	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $1.6	Strong Buy	Reiterates	$1.6	+101.61%	Sep 9, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $5	Strong Buy	Initiates	$5	+530.04%	Jul 18, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+3,680.24%	Dec 5, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+9,980.65%	Nov 1, 2022
Madhu Kumar B. Riley Securities	B. Riley Securities	Strong Buy Maintains $140 → $100	Strong Buy	Maintains	$140 → $100	+12,500.81%	Mar 13, 2020

More Analyst Ratings

Financial Forecast

Revenue This Year

4.28M

Revenue Next Year

n/a

from 4.28M

EPS This Year

-0.47

from -1.66

EPS Next Year

-0.47

from -0.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2028
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2028
Revenue	-	-	-	-	-	4.28M	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-20.00	-8.12	-5.69	-2.04	-1.66	-0.47	-0.47
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2028
High	4.4M	n/a
Avg	4.3M	n/a
Low	4.1M	n/a

Revenue Growth

Revenue Growth	2025	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.47	-0.42
Avg	-0.47	-0.47
Low	-0.47	-0.51

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.